跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
mRNA-Based Combination Vaccine
首页
药物
mRNA-Based Combination Vaccine
mRNA-Based Combination Vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
mRNA VACCINE FOR HERPES SIMPLEX VIRUS
US 20260224693 A1
申请人: UNIV HOUSTON SYSTEM
优先权: 2023
US
WO
2 件公开
MULTI-EPITOPE MRNA SARS-COV-2 VACCINE FOR BOOSTING IMMUNITY THROUGH THE ACTIVATION OF CD4 AND CD8 T CELLS AS WELL AS B LYMPHOCYTES
US 20250195639 A1
申请人: UNIV CALIFORNIA
优先权: 2022
US
Monkey pox virus mRNA vaccine based on nano-liposome and application of monkey pox virus mRNA vaccine
CN 118806887 A
申请人: SHANGHAI INST OF IMMUNE AND INFECTIOUS DYEING CHINESE ACADEMY OF SCIENCES
优先权: 2023
CN
RECOMBINANT PROTEIN VACCINE FOR PREVENTING AND TREATING SARS-COV-2 VARIANT JN.1, BA.2.86, AND XBB LINEAGES, COMBINATION DRUG AND USE
WO 2025189415 A1
申请人: WESTVAC BIOPHARMA CO LTD
优先权: 2024
WO
Mutant p53-R175H-based mRNA vaccine and application thereof
CN 118542935 A
申请人: SUZHOU HUAYUAN CELL BIOTECHNOLOGY CO LTD
优先权: 2024
CN
Herpes simplex virus mRNA vaccine as well as preparation method and application thereof
CN 121003692 A
申请人: UNIV TIANJIN MEDICAL
优先权: 2024
CN
Construction and application of mRNA vaccine based on adjuvant-antigen sequential control
CN 118649232 A
申请人: UNIV ZHEJIANG
优先权: 2024
CN
GPC3 derived antigen peptide vaccine, mRNA vaccine, saRNA vaccine and preparation method and application thereof
CN 120960408 A
申请人: HUNAN ACAD OF CHINESE MEDICINE
优先权: 2024
CN
一种用于预防猫传染性腹膜炎的广谱mRNA疫苗及其制备方法
CN 121668297 B
申请人: 瑞普生物股份有限公司
优先权: 2026
CN
药物
反馈